You are here:

  1. Home
  2. NICE Guidance
  3. NICE Advice
  4. Evidence summaries

Systemic juvenile idiopathic arthritis: canakinumab

  • Evidence summary
  • Reference number: ESNM36
  • Published:  18 March 2014

This evidence summary has been withdrawn. An NHS England clinical commissioning policy statement on biologic therapies for the treatment of juvenile idiopathic arthritis is available.

Back to top